Search Results - "Becher, P M"

Enhancement of endothelial nitric oxide synthase production reverses vascular dysfunction and inflammation in the hindlimbs of a rat model of diabetes by Riad, A, Westermann, D, Van Linthout, S, Mohr, Z, Uyulmaz, S, Becher, P. M, Rütten, H, Wohlfart, P, Peters, H, Schultheiss, H.-P, Tschöpe, C

“…Aims/hypothesis Reduced bioavailability of nitric oxide (NO) is a hallmark of diabetes mellitus-induced vascular complications. In the present study we…”
Get full text

Procedural Volume and Outcomes of Patients Undergoing VA-ECMO Support by Becher, P.M., Gossling, A., Schrage, B., Fluschnik, N., Seiffert, M., Bernhardt, A., Reichenspurner, H., Blankenberg, S., Westermann, D.

“…Venoarterial extracorporeal membrane oxygenation (VA-ECMO) is increasingly used in patients with critical cardiopulmonary failure. The association between…”
Get full text

Assessment of cardiac inflammation and remodeling during the development of streptozotocin-induced diabetic cardiomyopathy in vivo: A time course analysis by BECHER, P.M, LINDNER, D, FRÖHLICH, M, SAVVATIS, K, WESTERMANN, D, TSCHÖPE, C

“…In this study, we examined cardiac inflammation, fibrosis and left ventricular (LV) function during the development of streptozotocin (STZ)-induced diabetic…”
Get full text

Anticoagulation strategies in patients with atrial fibrillation after PCI or with ACS: The end of triple therapy? by Fluschnik, N., Becher, P. M., Schnabel, R., Blankenberg, S., Westermann, D.

“…Clinicians struggle daily with the optimal regimen for patients with an indication for antiplatelet therapy after stenting and in patients needing oral…”
Get full text

Predictors of acute ischemic strokes and subsequent mortality in patients hospitalized for percutaneous coronary interventions by Bay, B, Gossling, A, Remmel, M, Becher, P M, Schrage, B, Rimmele, D L, Thomalla, G, Blankenberg, S, Clemmensen, P, Brunner, F J, Waldeyer, C

Get full text

Temporal trends, patient characteristics and hospital volume outcomes after alcohol septal ablation and septal myectomy for treatment of obstructive hypertrophic cardiomyopathy by Becher, P M, Weimann, J, Brunner, F, Zengin-Sahm, E, Remmel, M, Schrage, B, Patten, M, Detter, C, Reichenspurner, H, Kirchhof, P, Blankenberg, S, Seiffert, M

Get full text

Temporal trends in incidence, patient characteristics, microbiology and in-hospital mortality in patients with infective endocarditis: a contemporary analysis of 86,469 cases between 2007 and 2019 by Becher, P M, Gossling, A, Fluschnik, N, Schrage, B, Seiffert, M, Schofer, N, Blankenberg, S, Kirchhof, P M, Westermann, D, Kalbacher, D

Get full text

Murine matrix metalloproteinase 13 and human matrix metalloproteinase 1 are involved in remodelling processes after myocardial infarction by Brauninger, H, Kruger, S, Becher, P M, Neumann, J T, Bacmeister, L, Voss, S, Kupsch, S, Zeller, T, Lammle, S, El-Armouche, A, Kirchhof, P, Blankenberg, S, Westermann, D, Lindner, D

Get full text

Peri-interventional ischemic stroke after coronary angiography: a large-scale nationwide cohort analysis from 2006 to 2020 by Bay, B, Gossling, A, Remmel, M, Koester, L, Blaum, C M, Becher, P M, Zengin-Sahm, E, Rimmele, D L, Clemmensen, P, Seiffert, M, Blankenberg, S, Brunner, F J, Waldeyer, C

Get full text

P6310Risk predictors of cardiac allograft vasculopathy after heart transplantation: results from the United States Organ Procurement and Transplantation Network by Fluschnik, N, Geelhoed, B, Becher, P M, Brunner, F J, Schrage, B, Knappe, D, Bernhardt, A, Blankenberg, S, Kobashigawa, J, Reichenspurner, H, Schnabel, R B, Magnussen, C

“…Abstract Background Cardiac allograft vasculopathy (CAV) is a major long-term complication after heart transplantation leading to chronic graft failure and…”
Get full text

P521Regulation of MMP activity influences cardiac fibrosis and cardiac inflammation during viral myocarditis by Lindner, D, Becher, P M, Stoffers, B, Hinrichs, S, Schwarzl, M, Bacmeister, L, Klingel, K, Blankenberg, S, Westermann, D

Get full text

281Impact of complications on VA-ECMO support for cardiopulmonary support: analysis of 8,351 adult patients in Germany from 2007 to 2015 by Becher, P M, Schrage, B, Schmack, B, Sinning, C, Fluschnik, N, Waldeyer, C, Seiffert, M, Neumann, J T, Bernhardt, A M, Reichenspurner, H, Zeymer, U, Thiele, H, Blankenberg, S, Twerenbold, R, Westermann, D

“…Abstract Background Venoarterial extracorporeal membrane oxygenation (VA-ECMO) is increasingly used for treatment of patients with critical cardiopulmonary…”
Get full text

Global burden of heart failure: a comprehensive and updated review of epidemiology by Savarese, Gianluigi, Becher, Peter Moritz, Lund, Lars H, Seferovic, Petar, Rosano, Giuseppe M C, Coats, Andrew J S

“…Heart Failure (HF) is a multi-faceted and life-threatening syndrome characterized by significant morbidity and mortality, poor functional capacity and quality…”
Get full text

2995Risk prediction in patients with venoarterial extracorporeal membrane oxygenation for cardiopulmonary support: insights from a German registry by Becher, P M, Sinning, C R, Schrage, B, Fluschnik, N F, Waldeyer, C R, Neumann, J T, Seiffert, M, Bernhardt, A, Schmack, B, Zeymer, U, Thiele, H, Reichenspurner, H, Blankenberg, S, Twerenbold, R, Westermann, D

Get full text

Anticoagulation strategies in patients with atrial fibrillation after PCI or with ACS by Fluschnik, N, Becher, P M, Schnabel, R, Blankenberg, S, Westermann, D

“…Clinicians struggle daily with the optimal regimen for patients with an indication for antiplatelet therapy after stenting and in patients needing oral…”
Get full text

An update on global epidemiology in heart failure by Becher, Peter Moritz, Lund, Lars H, Coats, Andrew J S, Savarese, Gianluigi

Get full text

Interleukin 23 deficiency leads to increased myocardial inflammation and impaired wound healing after experimental myocardial infarction by controling the function of cardiac fibroblasts by Savvatis, K., Pappritz, K., Becher, P. M., Lindner, D., Westermann, D., Schultheiss, H. P., Tschoepe, C.

Get full text

Adiponectin attenuates adverse cardiac remodeling in inflammatory heart disease by induction of matrix metalloproteinase-9 expression by Jenke, A., Becher, P. M., Poller, W., Schultheiss, H. P., Skurk, C.

Get full text

ISGylation exerts a protective function in virus-induced dilated cardiomyopathy by Voigt, A., Becher, M. P., Rahnefeld, A., Klingel, K., Knobeloch, K.- P.

Get full text

Biglcan is beneficial in angiotensin II induced heart failure by preventing cardiac inflammation and remodeling improving LV function and mortality by preventing transdifferentiation of myofibroblasts by Westermann, D., Becher, P. M., Lindner, D., Fischer, J. W., Tschoepe, C.

Get full text